Primary Site >> Colorectal Cancer

Gene >> CD1D

  • 2004
  • 2007
  • 2009
  • 2010
  • 2011
  • 2012
  • 2015
  • 2016
  • 2018
Ref: Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor.
PMID: 15251043
Ref: Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer.
PMID: 15259008
Ref: Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
PMID: 18038289
Ref: Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.
PMID: 19585513
Ref: CD1d-based combination therapy eradicates established tumors in mice.
PMID: 19620318
Ref: Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.
PMID: 19824039
Ref: Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells.
PMID: 19830696
Ref: CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers.
PMID: 21258883
Ref: Inhibition of dendritic cell maturation by the tumor microenvironment correlates with the survival of colorectal cancer patients following bevacizumab treatment.
PMID: 22675042
Ref: Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression.
PMID: 25304368
Ref: NKT cells mediate the recruitment of neutrophils by stimulating epithelial chemokine secretion during colitis.
PMID: 27063801
Ref: Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells.
PMID: 28401935
Ref: Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine.
PMID: 29861605